Basic Information
GPC Biotech is a German biopharmaceutical company that discovers and develops anti-cancer drugs. The company's portfolio includes Satraplatin, a platinum-based small molecule for prostate cancer; MAb 1D09C3, a monoclonal antibody for lymphoma; and RGB-286199, a small molecule for refractory cancers.
GPC Biotech AG
Munich,FreeStateofBavaria,Germany
51~100 people
August 01, 1997
--

